Clinical Trial Update: REStoring lymphoCytes Using NKTR-255* After chemoradiothErapy in Solid Tumors (RESCUE) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial (RESCUE) evaluating NKTR-255 after chemoradiotherapy in solid tumors, including lung cancer, is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• NKTR-255 (NKTR-255)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Lung Cancer | Phase 2 | Status: RECRUITING